SIMIELE, MARCO
SIMIELE, MARCO
SCIENZE MEDICHE
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy
2022-01-01 Manca, Alessandra; Palermiti, Alice; Mula, Jacopo; De Vivo, Elisa Delia; Zeaiter, Sandra; Simiele, Marco; De Nicolò, Amedeo; Cantù, Marco; Cusato, Jessica; D'Avolio, Antonio
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load
2010-01-01 Calcagno A; Milia MG; D'Avolio A; Ndayishimiyae P; Dusabimana P; Bonora S; Cusato J; Simiele M; Rostagno R; Siccardi M; Audagnotto S; Ghisetti V; Di Perri G.
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
2011-01-01 A. D'Avolio;M. Simiele;M. Siccardi;L. Baietto;M. Sciandra;V. Oddone;F. R. Stefani;S. Agati;J. Cusato;S. Bonora;G. Di Perri
A LC-MS method to quantify tenofovir urinary concentrations in treated patients
2015-01-01 Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio
A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect"
2016-01-01 D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G.
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma
2016-01-01 Ariaudo, Alessandra; Favata, Fabio; De Nicolò, Amedeo; Simiele, Marco; Paglietti, Luca; Boglione, Lucio; Cardellino, Chiara Simona; Carcieri, Chiara; Di Perri, Giovanni; D'Avolio, Antonio
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
2013-01-01 D'Avolio A;De Nicolò A;Agnesod D;Simiele M;Mohamed Abdi A;Dilly Penchala S;Boglione L;Cariti G;Di Perri G
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.
2010-01-01 A. D'Avolio;M. Simiele;L. Baietto;M. Siccardi;M. Sciandra;S. Patanella;S. Bonora;G. Di Perri
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma
2014-01-01 Marco Simiele;Lorena Baietto;Alessio Audino;Mauro Sciandra;Stefano Bonora;Giovanni Di Perri;Antonio D’Avolio
ABCB1 3435C>T e CYP2B6 516G>T possono predire le concentrazioni plasmatiche ottimali di Nevirapina
2009-01-01 Antonio D'Avolio; Marco Siccardi; Deborah Gatti; Lorena Baietto; Francesca Romana Stefani; Marco Simiele; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients
2008-01-01 Antonio Dʼavolio; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Marco Simiele; Valentina Oddone; Stefano Bonora; Giovanni Di Perri
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit
2023-01-01 Mula, Jacopo; Chiara, Francesco; Manca, Alessandra; Palermiti, Alice; Maiese, Domenico; Cusato, Jessica; Simiele, Marco; De Rosa, Francesco Giuseppe; Di Perri, Giovanni; De Nicolo, Amedeo; D'Avolio, Antonio
Are intracellular drug concentrations underestimated? The role of medium corpuscular volume (MCV) for a correct determination
2010-01-01 Marco Simiele; Antonio D’Avolio; Marco Siccardi; Lorena Baietto; Francesca Romana Stefani; Silvia Agati; Jessica Cusato; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients
2017-01-01 Focà, Emanuele; Calcagno, Andrea; Bonito, Andrea; Simiele, Marco; Domenighini, Elisabetta; D'Avolio, Antonio; Quiros Roldan, Eugenia; Trentini, Laura; Casari, Salvatore; Di Perri, Giovanni; Castelli, Francesco; Bonora, Stefano
Cannabinoids concentration variability in cannabis olive oil galenic preparations
2018-01-01 Carcieri, Chiara; Tomasello, Cristina; Simiele, Marco; DE NICOLO', Amedeo; Avataneo, Valeria; Canzoneri, Luca; Cusato, Jessica; DI PERRI, Giovanni; D'Avolio, Antonio
Cannabis FM2: optimization and standardization of galenic preparations.
2019-01-01 baratta francesca, simiele marco, pignata irene, iozzino beatrice, de pellegrini irene, torta riccardo, de luca anna, collino massimo, d'avolio antonio, brusa paola
Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability
2021-01-01 Baratta, Francesca; Simiele, Marco; Pignata, Irene; Ravetto Enri, Lorenzo; D’Avolio, Antonio; Torta, Riccardo; De Luca, Anna; Collino, Massimo; Brusa, Paola
Cerebrospinal Fluid Concentrations Above Drugs IC95s are Associated With CSF Viral Loads Below 50 copies/ml
2013-01-01 Calcagno A; Simiele M; Raviolo S; Alberione C; Audagnotto S; Alcantarini C; Bertucci R; D’Avolio A; Di Perri G; Bonora S.
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control.
2015-01-01 Calcagno A;Simiele M;Alberione MC;Bracchi M;Marinaro L;Ecclesia S;Di Perri G;D'Avolio A;Bonora S
Class-specific relative genetic contribution for key antiretroviral drugs
2015-01-01 Siccardi, Marco; Olagunju, Adeniyi; Simiele, Marco; D'Avolio, Antonio; Calcagno, Andrea; Di Perri, Giovanni; Bonora, Stefano; Owen, Andrew
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy | 2022 | Manca, Alessandra; Palermiti, Alice; Mula, Jacopo; De Vivo, Elisa Delia; Zeaiter, Sandra; Simiele, Marco; De Nicolò, Amedeo; Cantù, Marco; Cusato, Jessica; D'Avolio, Antonio | |
| A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load | 2010 | Calcagno A; Milia MG; D'Avolio A; Ndayishimiyae P; Dusabimana P; Bonora S; Cusato J; Simiele M; Rostagno R; Siccardi M; Audagnotto S; Ghisetti V; Di Perri G. | |
| A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. | 2011 | A. D'Avolio;M. Simiele;M. Siccardi;L. Baietto;M. Sciandra;V. Oddone;F. R. Stefani;S. Agati;J. Cusato;S. Bonora;G. Di Perri | |
| A LC-MS method to quantify tenofovir urinary concentrations in treated patients | 2015 | Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio | |
| A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect" | 2016 | D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G. | |
| A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma | 2016 | Ariaudo, Alessandra; Favata, Fabio; De Nicolò, Amedeo; Simiele, Marco; Paglietti, Luca; Boglione, Lucio; Cardellino, Chiara Simona; Carcieri, Chiara; Di Perri, Giovanni; D'Avolio, Antonio | |
| A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. | 2013 | D'Avolio A;De Nicolò A;Agnesod D;Simiele M;Mohamed Abdi A;Dilly Penchala S;Boglione L;Cariti G;Di Perri G | |
| A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. | 2010 | A. D'Avolio;M. Simiele;L. Baietto;M. Siccardi;M. Sciandra;S. Patanella;S. Bonora;G. Di Perri | |
| A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma | 2014 | Marco Simiele;Lorena Baietto;Alessio Audino;Mauro Sciandra;Stefano Bonora;Giovanni Di Perri;Antonio D’Avolio | |
| ABCB1 3435C>T e CYP2B6 516G>T possono predire le concentrazioni plasmatiche ottimali di Nevirapina | 2009 | Antonio D'Avolio; Marco Siccardi; Deborah Gatti; Lorena Baietto; Francesca Romana Stefani; Marco Simiele; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri | |
| An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients | 2008 | Antonio Dʼavolio; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Marco Simiele; Valentina Oddone; Stefano Bonora; Giovanni Di Perri | |
| Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit | 2023 | Mula, Jacopo; Chiara, Francesco; Manca, Alessandra; Palermiti, Alice; Maiese, Domenico; Cusato, Jessica; Simiele, Marco; De Rosa, Francesco Giuseppe; Di Perri, Giovanni; De Nicolo, Amedeo; D'Avolio, Antonio | |
| Are intracellular drug concentrations underestimated? The role of medium corpuscular volume (MCV) for a correct determination | 2010 | Marco Simiele; Antonio D’Avolio; Marco Siccardi; Lorena Baietto; Francesca Romana Stefani; Silvia Agati; Jessica Cusato; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri | |
| Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients | 2017 | Focà, Emanuele; Calcagno, Andrea; Bonito, Andrea; Simiele, Marco; Domenighini, Elisabetta; D'Avolio, Antonio; Quiros Roldan, Eugenia; Trentini, Laura; Casari, Salvatore; Di Perri, Giovanni; Castelli, Francesco; Bonora, Stefano | |
| Cannabinoids concentration variability in cannabis olive oil galenic preparations | 2018 | Carcieri, Chiara; Tomasello, Cristina; Simiele, Marco; DE NICOLO', Amedeo; Avataneo, Valeria; Canzoneri, Luca; Cusato, Jessica; DI PERRI, Giovanni; D'Avolio, Antonio | |
| Cannabis FM2: optimization and standardization of galenic preparations. | 2019 | baratta francesca, simiele marco, pignata irene, iozzino beatrice, de pellegrini irene, torta riccardo, de luca anna, collino massimo, d'avolio antonio, brusa paola | |
| Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability | 2021 | Baratta, Francesca; Simiele, Marco; Pignata, Irene; Ravetto Enri, Lorenzo; D’Avolio, Antonio; Torta, Riccardo; De Luca, Anna; Collino, Massimo; Brusa, Paola | |
| Cerebrospinal Fluid Concentrations Above Drugs IC95s are Associated With CSF Viral Loads Below 50 copies/ml | 2013 | Calcagno A; Simiele M; Raviolo S; Alberione C; Audagnotto S; Alcantarini C; Bertucci R; D’Avolio A; Di Perri G; Bonora S. | |
| Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control. | 2015 | Calcagno A;Simiele M;Alberione MC;Bracchi M;Marinaro L;Ecclesia S;Di Perri G;D'Avolio A;Bonora S | |
| Class-specific relative genetic contribution for key antiretroviral drugs | 2015 | Siccardi, Marco; Olagunju, Adeniyi; Simiele, Marco; D'Avolio, Antonio; Calcagno, Andrea; Di Perri, Giovanni; Bonora, Stefano; Owen, Andrew |